JOHNSON & Johnson has
announced the purchase
of privately held Aragon
Pharmaceuticals, which specialises
in the development of hormonally
based cancer treatments.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 19 Jun 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Jun 13
WITH close to half of Australians expected to experience a mental illness at some stage of their life, research conducted by Griffith University found consumers believe community pharmacists are well placed to provide mental health promotion.